Advanced Microbubbles

Newark, United States Founded: 2020 • Age: 6 yrs
Manufacturer of Mmonodisperse Size-Isolated Microbubble (SIMBs) ultrasound contrast agents (UCAs)

About Advanced Microbubbles

Advanced Microbubbles is a company based in Newark (United States) founded in 2020 by Shashank A Sirsi.. Advanced Microbubbles has raised $250 thousand across 1 funding round from investors including IndieBio. Advanced Microbubbles offers products and services including Ultrasound-Triggered Microbubbles. Advanced Microbubbles operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.

  • Headquarter Newark, United States
  • Founders Shashank A Sirsi
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Advanced Microbubbles Inc
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $250 K (USD)

    in 1 rounds

  • Latest Funding Round
    $250 K (USD), Seed

    Oct 27, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Advanced Microbubbles

Advanced Microbubbles offers a comprehensive portfolio of products and services, including Ultrasound-Triggered Microbubbles. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables precise drug and gene delivery through ultrasound activation.

People of Advanced Microbubbles
Headcount 1-10
Employee Profiles 2
Board Members and Advisors 4
Employee Profiles
People
Jameel Feshitan
Co-Founder & CEO
People
Shashank Sirsi
Co-Founder & CSO

Unlock access to complete

Board Members and Advisors
people
Badri Rengarajan
Rare Disease Advisor
people
Joan Vidal-Jove
Clinical Advisor
people
Steve Tyrell
Business & Regulatory Advisor
people
Theodore W. Laetsch
Pediatric Oncology Advisor

Unlock access to complete

Funding Insights of Advanced Microbubbles

Advanced Microbubbles has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $250,000
  • First Round

    (27 Oct 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2020 Amount Seed - Advanced Microbubbles Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Advanced Microbubbles

Advanced Microbubbles has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Biotech startups are accelerated through IndieBio's focused programs.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Advanced Microbubbles

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Advanced Microbubbles

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Advanced Microbubbles Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Advanced Microbubbles

Advanced Microbubbles operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
domain founded_year HQ Location
APIs are developed and manufactured for therapeutic areas.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Advanced Microbubbles

Frequently Asked Questions about Advanced Microbubbles

When was Advanced Microbubbles founded?

Advanced Microbubbles was founded in 2020.

Where is Advanced Microbubbles located?

Advanced Microbubbles is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.

Is Advanced Microbubbles a funded company?

Advanced Microbubbles is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on Oct 27, 2020.

What does Advanced Microbubbles do?

Advanced Microbubbles manufacturer of mmonodisperse size-isolated microbubble (simbs) ultrasound contrast agents (ucas) through providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, and api production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

Who are the top competitors of Advanced Microbubbles?

Advanced Microbubbles's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.

What products or services does Advanced Microbubbles offer?

Advanced Microbubbles offers Ultrasound-Triggered Microbubbles.

Who are Advanced Microbubbles's investors?

Advanced Microbubbles has 1 investor. Key investors include IndieBio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available